Andy Pasternak - 18 Feb 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
EVP and Chief Business Officer
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
18 Feb 2022
Net transactions value
-$124,499
Form type
4
Filing time
18 Feb 2022, 15:42:45 UTC
Previous filing
06 Jan 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Sale $124,499 -1,313 -3.2% $94.82 39,659 18 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021.